Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Exchange Rate Effect (2023 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Exchange Rate Effect for 3 consecutive years, with $351000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 1571.43% to $351000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$329000.0 through Dec 2025, down 928.12% year-over-year, with the annual reading at -$329000.0 for FY2025, 928.12% down from the prior year.
  • Exchange Rate Effect hit $351000.0 in Q4 2025 for Ironwood Pharmaceuticals, up from -$26000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $351000.0 in Q4 2025 to a low of -$647000.0 in Q2 2025.
  • Historically, Exchange Rate Effect has averaged -$45666.7 across 3 years, with a median of -$26000.0 in 2024.
  • Biggest YoY gain for Exchange Rate Effect was 1571.43% in 2025; the steepest drop was 1168.63% in 2025.
  • Year by year, Exchange Rate Effect stood at -$50000.0 in 2023, then surged by 142.0% to $21000.0 in 2024, then soared by 1571.43% to $351000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for IRWD at $351000.0 in Q4 2025, -$26000.0 in Q3 2025, and -$647000.0 in Q2 2025.